Interaction Checker

Cookies help us deliver our services. By using our services, you agree to our use of cookies. Learn more

Two new HCC primaries: lenvatinib and sorafenib

Friday 12 February 2021

We have added lenvatinib and sorafenib to the interaction checker, completing our hepatocellular carcinoma indication. All the PDFs have been updated, and there are two new PK factsheets for the new primaries.

Awards and commendations
bma-foundation-for-medical-research british-medical-journal-2018 queens_aniversary_prize_2017 rcp-excellence-patient-care-awards-2017 building_better_healthcare_awards_2016